(Q47743073)

5 February 2018

title

Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women. (English)

1 reference

5 February 2018

0 references

1 reference

1 reference

Beth Smith

1

1 reference

5 February 2018

Steven L Dubovsky

series ordinal

2

1 reference

5 February 2018

language of work or name

English

0 references

publication date

11 October 2017

1 reference

5 February 2018

Expert Opinion on Pharmacotherapy

published in

1 reference

5 February 2018

volume

18

1 reference

5 February 2018

issue

16

1 reference

5 February 2018

page(s)

1703-1719

1 reference

5 February 2018

Perinatal depression: a systematic review of prevalence and incidence

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

On the impact of episode sensitization on the course of recurrent affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Long-term response to successful acute pharmacological treatment of psychotic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

The relationship between childhood trauma history and the psychotic subtype of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

What we don't know about psychotic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Contribution of suicide and injuries to pregnancy-related mortality in low-income and middle-income countries: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Effects of perinatal mental disorders on the fetus and child

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

The impact of maternal depression in pregnancy on early child development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prenatal maternal depression associates with microstructure of right amygdala in neonates at birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prepartum and Postpartum Maternal Depressive Symptoms Are Related to Children's Brain Structure in Preschool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prolactin, a potential mediator of reduced social interactive behavior in newborn infants following maternal perinatal depressive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Foetal exposure to maternal depression predicts cortisol responses in infants: findings from rural South India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prenatal maternal stress programs infant stress regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Predictors of neonatal hypothalamic-pituitary-adrenal axis activity at delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal depression and infant cortisol: influences of timing, comorbidity and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antipsychotic therapy during early and late pregnancy. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

A review of the use of psychotropic medication in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

National trends in antidepressant medication treatment among publicly insured pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Use of antidepressants during pregnancy and the risk of spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Sertraline use during pregnancy and the risk of major malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant use during pregnancy and childhood autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant exposure in pregnancy and risk of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Ethical and Clinical Dilemmas in Using Psychotropic Medications During Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Sertraline and breastfeeding: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant drugs and breastfeeding: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Serotonin reuptake inhibitors and breastfeeding: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant medication use during breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Serotonin syndrome in a breast-fed neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant use in pregnancy and the risk of cardiac defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Tricyclic antidepressants in pregnancy and puerperium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Neurodevelopment of children exposed in utero to antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Clomipramine concentration and withdrawal symptoms in 10 neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antidepressant use and risk for preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Delivery outcome in relation to maternal use of some recently introduced antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal use of bupropion and risk for congenital heart defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

ECT in pregnancy: a review of the literature from 1941 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Electroconvulsive therapy for mood disorders in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Electroconvulsive therapy in pregnant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Fetal spasms after the administration of electroconvulsive therapy in pregnancy: our experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

A Systematic Review of the Safety of Electroconvulsive Therapy Use During the First Trimester of Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Bipolar Depression: Pregnancy, Postpartum, and Lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Episodes of mood disorders in 2,252 pregnancies and postpartum periods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Perinatal episodes across the mood disorder spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

What is a "mood stabilizer"? An evidence-based response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Case report and review of the perinatal implications of maternal lithium use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Drug treatment for mood disorders in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Lithium toxicity profile: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Lithium Use in Pregnancy and the Risk of Cardiac Malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Lamotrigine in epilepsy, pregnancy and psychiatry--a drug for all seasons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Breastfeeding in women with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Use of psychotropic medication during pregnancy and the postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Autism spectrum disorders following in utero exposure to antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal use of antipsychotics in early pregnancy and delivery outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Use of Antipsychotics During Pregnancy: Pregnant Women Get Sick-Sick Women Get Pregnant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Antipsychotic use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for the treatment of major depressive disorder, a randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Psychosis within vs outside of major mood episodes: a key prognostic and diagnostic criterion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

The treatment of psychotic depression: is there consensus among guidelines and psychiatrists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Modeling drug passage into human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Calcium antagonists in mania: a double-blind study of verapamil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1391789

10.1080/14656566.2017.1391789

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

29019422

1 reference

5 February 2018